131 related articles for article (PubMed ID: 37140677)
1. Performance of the pooled cohort equations in cancer survivors: the Atherosclerosis Risk in Communities study.
Polter EJ; Blaes A; Wolfson J; Lutsey PL; Florido R; Joshu CE; Guha A; Platz EA; Prizment A
J Cancer Surviv; 2024 Feb; 18(1):124-134. PubMed ID: 37140677
[TBL] [Abstract][Full Text] [Related]
2. Performance of the American Heart Association/American College of Cardiology Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Self-reported Physical Activity Levels.
Pandey A; Mehta A; Paluch A; Ning H; Carnethon MR; Allen NB; Michos ED; Berry JD; Lloyd-Jones DM; Wilkins JT
JAMA Cardiol; 2021 Jun; 6(6):690-696. PubMed ID: 33909016
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort.
Emdin CA; Khera AV; Natarajan P; Klarin D; Baber U; Mehran R; Rader DJ; Fuster V; Kathiresan S
Am J Cardiol; 2017 Mar; 119(6):881-885. PubMed ID: 28061997
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Risk Associated With Social Determinants of Health at Individual and Area Levels.
Xia M; An J; Safford MM; Colantonio LD; Sims M; Reynolds K; Moran AE; Zhang Y
JAMA Netw Open; 2024 Apr; 7(4):e248584. PubMed ID: 38669015
[TBL] [Abstract][Full Text] [Related]
5. Comparison of State-of-the-Art Neural Network Survival Models with the Pooled Cohort Equations for Cardiovascular Disease Risk Prediction.
Deng Y; Liu L; Jiang H; Peng Y; Wei Y; Zhou Z; Zhong Y; Zhao Y; Yang X; Yu J; Lu Z; Kho A; Ning H; Allen NB; Wilkins JT; Liu K; Lloyd-Jones DM; Zhao L
BMC Med Res Methodol; 2023 Jan; 23(1):22. PubMed ID: 36694118
[TBL] [Abstract][Full Text] [Related]
6. [Application of the China-PAR risk prediction model for atherosclerotic cardiovascular disease in a rural northern Chinese population].
Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Huang SP; Dou HD; Gao P; Hu YH
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):439-445. PubMed ID: 28628144
[TBL] [Abstract][Full Text] [Related]
7. Prediction of 10-year atherosclerotic cardiovascular disease risk among community residents in Shanghai, China - a comparative analysis of risk algorithms.
Zhang Y; Zhao Q; Ng N; Wang W; Wang N; Qiu Y; Yu Y; Xiang Y; Cui S; Zhu M; Jiang Y; Zhao G
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2058-2067. PubMed ID: 34090771
[TBL] [Abstract][Full Text] [Related]
8. Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice.
Medina-Inojosa JR; Somers VK; Garcia M; Thomas RJ; Allison T; Chaudry R; Wood-Wentz CM; Bailey KR; Mulvagh SL; Lopez-Jimenez F
J Am Coll Cardiol; 2023 Oct; 82(15):1499-1508. PubMed ID: 37793746
[TBL] [Abstract][Full Text] [Related]
9. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index.
Khera R; Pandey A; Ayers CR; Carnethon MR; Greenland P; Ndumele CE; Nambi V; Seliger SL; Chaves PHM; Safford MM; Cushman M; Xanthakis V; Vasan RS; Mentz RJ; Correa A; Lloyd-Jones DM; Berry JD; de Lemos JA; Neeland IJ
JAMA Netw Open; 2020 Oct; 3(10):e2023242. PubMed ID: 33119108
[TBL] [Abstract][Full Text] [Related]
10. A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort.
Santos-Ferreira C; Baptista R; Oliveira-Santos M; Moura JP; Gonçalves L
BMC Cardiovasc Disord; 2020 Jun; 20(1):301. PubMed ID: 32560700
[TBL] [Abstract][Full Text] [Related]
11. Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification.
Ghosh AK; Venkatraman S; Nanna MG; Safford MM; Colantonio LD; Brown TM; Pinheiro LC; Peterson ED; Navar AM; Sterling MR; Soroka O; Nahid M; Banerjee S; Goyal P
JAMA Cardiol; 2024 Jan; 9(1):55-62. PubMed ID: 38055247
[TBL] [Abstract][Full Text] [Related]
12. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities study.
Henderson K; Kaufman B; Rotter JS; Stearns S; Sueta CAA; Foraker R; Ho PM; Chang PP
BMJ Open; 2022 Nov; 12(11):e058777. PubMed ID: 36343998
[TBL] [Abstract][Full Text] [Related]
14. Prediction of 10-year Atherosclerotic Cardiovascular Disease Risk among Adults Aged 40-79 Years in China: a Nationally Representative Survey.
Zhang M; Jiang Y; Wang LM; Li YC; Huang ZJ; Li JH; Zhou MG; Zhao WH;
Biomed Environ Sci; 2017 Apr; 30(4):244-254. PubMed ID: 28494834
[TBL] [Abstract][Full Text] [Related]
15. Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort.
Bae JH; Moon MK; Oh S; Koo BK; Cho NH; Lee MK
Diabetes Metab J; 2020 Jun; 44(3):458-469. PubMed ID: 31950769
[TBL] [Abstract][Full Text] [Related]
16. The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease.
Jung KJ; Jang Y; Oh DJ; Oh BH; Lee SH; Park SW; Seung KB; Kim HK; Yun YD; Choi SH; Sung J; Lee TY; Kim SH; Koh SB; Kim MC; Chang Kim H; Kimm H; Nam C; Park S; Jee SH
Atherosclerosis; 2015 Sep; 242(1):367-75. PubMed ID: 26255683
[TBL] [Abstract][Full Text] [Related]
17. Universal Risk Prediction for Individuals With and Without Atherosclerotic Cardiovascular Disease.
Mok Y; Dardari Z; Sang Y; Hu X; Bancks MP; Mathews L; Hoogeveen RC; Koton S; Blaha MJ; Post WS; Ballantyne CM; Coresh J; Rosamond W; Matsushita K
J Am Coll Cardiol; 2024 Feb; 83(5):562-573. PubMed ID: 38296400
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.
Pylypchuk R; Wells S; Kerr A; Poppe K; Riddell T; Harwood M; Exeter D; Mehta S; Grey C; Wu BP; Metcalf P; Warren J; Harrison J; Marshall R; Jackson R
Lancet; 2018 May; 391(10133):1897-1907. PubMed ID: 29735391
[TBL] [Abstract][Full Text] [Related]
19. Performance of atherosclerotic cardiovascular risk prediction models in a rural Northern Chinese population: Results from the Fangshan Cohort Study.
Tang X; Zhang D; He L; Wu N; Si Y; Cao Y; Huang S; Li N; Li J; Dou H; Gao P; Hu Y
Am Heart J; 2019 May; 211():34-44. PubMed ID: 30831332
[TBL] [Abstract][Full Text] [Related]
20. Estimating the performance of three cardiovascular disease risk scores: the Estonian Biobank cohort study.
Saar A; Läll K; Alver M; Marandi T; Ainla T; Eha J; Metspalu A; Fischer K
J Epidemiol Community Health; 2019 Mar; 73(3):272-277. PubMed ID: 30635435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
